196 related articles for article (PubMed ID: 38546616)
1. Depressive Symptoms, Systemic Inflammation, and Survival Among Patients With Head and Neck Cancer.
Cash E; Albert C; Palmer I; Polzin B; Kabithe A; Crawford D; Bumpous JM; Sephton SE
JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):405-413. PubMed ID: 38546616
[TBL] [Abstract][Full Text] [Related]
2. Depressive symptoms and actigraphy-measured circadian disruption predict head and neck cancer survival.
Cash E; Duck CR; Brinkman C; Rebholz W; Albert C; Worthen M; Jusufbegovic M; Wilson L; Bumpous JM
Psychooncology; 2018 Oct; 27(10):2500-2507. PubMed ID: 30117225
[TBL] [Abstract][Full Text] [Related]
3. Depressive symptoms in relation to overall survival in people with head and neck cancer: A longitudinal cohort study.
Jansen F; Verdonck-de Leeuw IM; Cuijpers P; Leemans CR; Waterboer T; Pawlita M; Penfold C; Thomas SJ; Waylen A; Ness AR
Psychooncology; 2018 Sep; 27(9):2245-2256. PubMed ID: 29927013
[TBL] [Abstract][Full Text] [Related]
4. Depressive symptoms predict head and neck cancer survival: Examining plausible behavioral and biological pathways.
Zimmaro LA; Sephton SE; Siwik CJ; Phillips KM; Rebholz WN; Kraemer HC; Giese-Davis J; Wilson L; Bumpous JM; Cash ED
Cancer; 2018 Mar; 124(5):1053-1060. PubMed ID: 29355901
[TBL] [Abstract][Full Text] [Related]
5. Association of Type of Treatment Facility With Overall Survival After a Diagnosis of Head and Neck Cancer.
Carey RM; Fathy R; Shah RR; Rajasekaran K; Cannady SB; Newman JG; Ibrahim SA; Brant JA
JAMA Netw Open; 2020 Jan; 3(1):e1919697. PubMed ID: 31977060
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer.
Kim SA; Roh JL; Lee SA; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Cancer; 2016 Jan; 122(1):131-40. PubMed ID: 26371775
[TBL] [Abstract][Full Text] [Related]
7. The relationship between depressive symptoms, quality of life, and swallowing function in head and neck cancer patients 1 year after definitive therapy.
Lin BM; Starmer HM; Gourin CG
Laryngoscope; 2012 Jul; 122(7):1518-25. PubMed ID: 22467530
[TBL] [Abstract][Full Text] [Related]
8. Combined influence of nutritional and inflammatory status and depressive symptoms on mortality among US cancer survivors: Findings from the NHANES.
Yao J; Chen X; Meng F; Cao H; Shu X
Brain Behav Immun; 2024 Jan; 115():109-117. PubMed ID: 37820973
[TBL] [Abstract][Full Text] [Related]
9. A predictive survival model for patients with stage IV oropharyngeal squamous cell carcinoma treated with chemoradiation.
Yeh P; Chang CM; Liao LJ; Wu CY; Hsieh CH; Shueng PW; Cheng PW; Lo WC
Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):369-377. PubMed ID: 37594545
[TBL] [Abstract][Full Text] [Related]
10. Association of Human Papillomavirus Status With Suicide Risk Among Patients With Head and Neck Cancer.
Chakoma T; Moon PK; Osazuwa-Peters OL; Megwalu UC; Osazuwa-Peters N
JAMA Otolaryngol Head Neck Surg; 2023 Apr; 149(4):291-299. PubMed ID: 36795392
[TBL] [Abstract][Full Text] [Related]
11. Depression as a predictor of postoperative functional performance status (PFPS) and treatment adherence in head and neck cancer patients: a prospective study.
Barber B; Dergousoff J; Nesbitt M; Mitchell N; Harris J; O'Connell D; Côté D; Biron V; Seikaly H
J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):38. PubMed ID: 26385356
[TBL] [Abstract][Full Text] [Related]
12. The impact of compliance in posttreatment surveillance in head and neck squamous cell carcinoma.
Deutschmann MW; Sykes KJ; Harbison J; Cabrera-Muffly C; Shnayder Y
JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):519-25. PubMed ID: 25950859
[TBL] [Abstract][Full Text] [Related]
13. Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients?
Choi SH; Terrell JE; Bradford CR; Ghanem T; Spector ME; Wolf GT; Lipkus IM; Duffy SA
Nicotine Tob Res; 2016 Dec; 18(12):2216-2224. PubMed ID: 27613928
[TBL] [Abstract][Full Text] [Related]
14. Body image and depressive symptoms in patients with head and neck cancer: an important relationship.
Rhoten BA; Deng J; Dietrich MS; Murphy B; Ridner SH
Support Care Cancer; 2014 Nov; 22(11):3053-60. PubMed ID: 24925049
[TBL] [Abstract][Full Text] [Related]
15. Using the Patient Health Questionnaire-2 to improve depression screening in head and neck cancer patients.
Garber BB; Chen J; Beliveau A; Farwell DG; Bewley AF; Birkeland AC; Abouyared M
Am J Otolaryngol; 2023; 44(2):103724. PubMed ID: 36493469
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in head and neck cancer survivors: impact of pretreatment depressive symptoms.
Howren MB; Christensen AJ; Karnell LH; Funk GF
Health Psychol; 2010 Jan; 29(1):65-71. PubMed ID: 20063937
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma.
Duffy SA; Ronis DL; McLean S; Fowler KE; Gruber SB; Wolf GT; Terrell JE
J Clin Oncol; 2009 Apr; 27(12):1969-75. PubMed ID: 19289626
[TBL] [Abstract][Full Text] [Related]
18. Association of Body Mass Index With Outcomes Among Patients With Head and Neck Cancer Treated With Chemoradiotherapy.
Ma SJ; Khan M; Chatterjee U; Santhosh S; Hashmi M; Gill J; Yu B; Iovoli A; Farrugia M; Wooten K; Gupta V; McSpadden R; Yu H; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Seshadri M; Ray AD; Repasky E; Singh AK
JAMA Netw Open; 2023 Jun; 6(6):e2320513. PubMed ID: 37368400
[TBL] [Abstract][Full Text] [Related]
19. The prognostic impact of depression or depressive symptoms on patients with head and neck cancer: A systematic review and meta-analysis.
Van der Elst S; Bardash Y; Wotman M; Kraus D; Tham T
Head Neck; 2021 Nov; 43(11):3608-3617. PubMed ID: 34525238
[TBL] [Abstract][Full Text] [Related]
20. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
Iovoli AJ; Hermann GM; Ma SJ; Platek AJ; Farrugia MK; Yau E; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Singh AK
JAMA Netw Open; 2020 Jun; 3(6):e207199. PubMed ID: 32602907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
